Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
暂无分享,去创建一个
Kevin J. Emmett | R. Melamed | R. Rabadán | R. Phelps | G. Rajan | D. Silvers | G. Brunner | Iraz T. Aydin | J. Celebi | I. Aydin
[1] R. Dummer,et al. The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.
[2] Steven J. M. Jones,et al. Genomic Classification of Cutaneous Melanoma , 2015, Cell.
[3] Trevor J Pugh,et al. Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.
[4] R. Melamed,et al. FBXW7 mutations in melanoma and a new therapeutic paradigm. , 2014, Journal of the National Cancer Institute.
[5] N. Dhomen,et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53 , 2014, Nature.
[6] X. Su,et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. , 2014, The Journal of investigative dermatology.
[7] Raul Rabadan,et al. SAVI: a statistical algorithm for variant frequency identification , 2013, BMC Systems Biology.
[8] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[9] K. Flaherty,et al. Elucidating distinct roles for NF1 in melanomagenesis. , 2013, Cancer discovery.
[10] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[11] Jan V Hirschmann,et al. Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. , 2012, Journal of the American Academy of Dermatology.
[12] A. Sivachenko,et al. A Landscape of Driver Mutations in Melanoma , 2012, Cell.
[13] Matthew J. Davis,et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.
[14] K. Duffy,et al. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. , 2012, Journal of the American Academy of Dermatology.
[15] K. Duffy,et al. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. , 2012, Journal of the American Academy of Dermatology.
[16] L. Chin,et al. Melanoma: from mutations to medicine. , 2012, Genes & development.
[17] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[18] C. V. Jongeneel,et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.
[19] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[20] David E Elder,et al. Dysplastic naevi: an update , 2010, Histopathology.
[21] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[22] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[23] H. Kerl,et al. Non-random spatial association of melanoma and naevi--a morphometric analysis. , 1999, Melanoma research.
[24] A. Marghoob,et al. Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. , 1995, Journal of the American Academy of Dermatology.